The Master of Science degree in Integrative Pharmacology is an online program designed to train individuals in whole animal and organ systems-level pharmacology as well as to develop knowledge in business acumen. The program provides advanced science and practical knowledge in integrative pharmacology and is designed for individuals who seek career advancement and leadership roles in academic, government or industrial laboratories. The Master of Science degree in Integrative Pharmacology is especially suited to those individuals with some professional experience in laboratory research, but all graduates of biology or chemistry programs will benefit. Course work provides freedom to explore those physiological systems that will allow students to continue to build upon their current research endeavors, while providing skills to interface with colleagues in regulatory affairs, production, and marketing. All courses are offered online in order to provide full opportunity for students regardless of their geographic location or work schedules.
Master of Science
In addition to meeting the requirements of the university and of the College of Osteopathic Medicine, students must meet the requirements specified below.
Admission
Applicants will be accepted into the program after review of application materials by an admissions committee rom the department. A faculty member in the Department of Pharmacology and Toxicology will serve as the student’s academic advisor.
Applicants must have completed a bachelor’s degree from an accredited college or university, with at least 3 credits in chemistry and 3 credits in a biological science. Preference will be given to applicants with undergraduate degrees in biology, chemistry or related sciences and who are currently employed in an academic, government or industrial laboratory. A letter of intent outlining the student's interests and professional goals and two letters of recommendation are required for consideration for admission.
Requirements for the Master of Science Degree in Integrative Pharmacology
|
|
|
|
|
|
|
|
| The student must complete at least 31 credits under Plan B (without thesis). Students may not earn more than 9 credits at the 400-level. |
|
| 1. |
All of the following courses (14 credits): |
|
|
PHM |
813 |
Cardiovascular Pharmacology and Toxicology |
3 |
|
PHM |
819 |
Principles of Drug-Tissue Interactions |
2 |
|
PHM |
822 |
Academic and Research Integrity |
1 |
|
PHM |
830 |
Experimental Design and Data Analysis |
3 |
|
PHM |
832 |
Applied Integrative Pharmacology Laboratory |
3 |
|
PHM |
850 |
Communications for Scientists |
2 |
| 2. |
One of the following courses (2 to 6 credits): |
|
|
PHM |
895 |
Applied Project in Integrative Pharmacology |
3 or 4 |
|
or |
|
|
|
|
PHM |
982 |
Master of Science Capstone Literature Review |
2 |
| 3. |
Science electives (as needed to total 31 credits for the degree with a minimum of 4 credits at the 800-level): |
|
|
BLD |
830 |
Concepts in Molecular Biology |
2 |
|
HM |
803 |
Epidemiology and Public Health |
3 |
|
HM |
806 |
Environmental Factors of Health |
3 |
|
HM |
833 |
Introduction to Pharmaceutical Counterfeiting and Public Health |
3 |
|
PHM |
430 |
Human Pharmacology |
3 |
|
PHM |
431 |
Pharmacology of Drug Addiction |
3 |
|
PHM |
450 |
Introduction to Chemical Toxicology |
3 |
|
PHM |
461 |
Tropical Medicine Pharmacology |
2 |
|
PHM |
483 |
Chemotherapy of Infectious Diseases |
3 |
|
PHM |
492 |
Pharmacotherapy of Human Viral Infections |
2 |
|
PHM |
811 |
Global Health: Pharmacology and Toxicology Perspective |
2 |
|
PHM |
817 |
Neurotoxicology |
2 |
|
PHM |
818 |
Practical Pharmacokinetics/Pharmacodynamics Modeling and Simulation in Drug Development |
1 |
|
PHM |
823 |
Current Topics in Pharmacology and Toxicology |
1 |
|
PHM |
828 |
Concepts in Carcinogenesis |
2 |
|
PHM |
829 |
Neuropharmacology |
2 |
|
PHM |
831 |
Endocrine Pharmacology and Toxicology |
2 |
|
PHM |
833 |
Gastro-Intestinal and Liver Pharmacology and Toxicology |
2 |
|
PHM |
834 |
Respiratory Pharmacology |
2 |
|
PHM |
835 |
Biopharmaceuticals: From Development to Manufacturing |
3 |
|
PHM |
837 |
Autonomic Pharmacology |
1 |
|
PHM |
838 |
Pharmacogenomics |
2 |
|
PHM |
840 |
Safety Pharmacology |
2 |
|
PHM |
841 |
Cellular and Molecular Toxicology |
3 |
|
VM |
812 |
Food Safety Toxicology |
3 |
| 4. |
Professional electives (4 to 7 credits): |
|
|
BLD |
842 |
Managing Biomedical Laboratory Operations |
2 |
|
PHM |
851 |
Intellectual Property and Patent Law for Biomedical Sciences |
2 |
|
PHM |
854 |
Leadership and Team-Building for Biomedical Research |
2 |
|
PHM |
855 |
The Business of Biomedical Research Organizations |
2 |
|
PHM |
857 |
Project Management |
2 |
|
PHM |
858 |
Project Management and the Drug Development Process |
3 |
Academic Standards
Students enrolled in the Master of Science degree in Integrative Pharmacology are expected to maintain a minimum cumulative grade-point average of 3.0. A student who does not maintain a 3.0 grade-point average will be placed on probation. Students will be given one year of enrollment to achieve a 3.0 cumulative grade-point average, otherwise, dismissal from the program may result.